Evidence map›Paper›PMID 36968981›Full record

ArticleEndoscopy international open2023

Comparison of the hybrid and partial stent-in-stent method for endoscopic three-segment drainage for unresectable malignant hilar biliary obstruction.

Motohiro Yoshinari, Susumu Hijioka, Yoshikuni Nagashio, Yuta Maruki, Akihiro Ohba, Yuki Kawasaki, Kotaro Takeshita, Chigusa Morizane, Yasuhito Tanaka, Takuji Okusaka

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endoscopy international open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Motohiro YoshinariNational Cancer Center Hospital, Department of Hepatobiliary and Pancreatic Oncology, Tokyo, Japan.ORCID 0000-0003-4478-8664
Susumu HijiokaNational Cancer Center Hospital, Department of Hepatobiliary and Pancreatic Oncology, Tokyo, Japan.ORCID 0000-0002-0394-6876
Yoshikuni NagashioNational Cancer Center Hospital, Department of Hepatobiliary and Pancreatic Oncology, Tokyo, Japan.
Yuta MarukiNational Cancer Center Hospital, Department of Hepatobiliary and Pancreatic Oncology, Tokyo, Japan.
Akihiro OhbaNational Cancer Center Hospital, Department of Hepatobiliary and Pancreatic Oncology, Tokyo, Japan.
Yuki KawasakiNational Cancer Center Hospital, Department of Hepatobiliary and Pancreatic Oncology, Tokyo, Japan.
Kotaro TakeshitaNational Cancer Center Hospital, Department of Hepatobiliary and Pancreatic Oncology, Tokyo, Japan.
Chigusa MorizaneNational Cancer Center Hospital, Department of Hepatobiliary and Pancreatic Oncology, Tokyo, Japan.
Yasuhito TanakaKumamoto University, Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto, Japan.
Takuji OkusakaNational Cancer Center Hospital, Department of Hepatobiliary and Pancreatic Oncology, Tokyo, Japan.
Kumamoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36968981
PMCPMC10036201
OpenAlexW4321434696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.